Gastroenterology · Acibadem Fulya Hospital, İstanbul Prof. Hülya Hamzaoğlu, MD
✓ Medically verified profileProf. Hülya Hamzaoğlu, MD
Prof. Hülya Hamzaoğlu, MD is a gastroenterology specialist at Acibadem Fulya Hospital in İstanbul. She treats inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, biliary tract diseases, gastroenteritis, reflux, gastritis and dyspepsia, and hemorrhoids and anorectal diseases, and performs gastroscopy, colonoscopy and esophagoscopy. She consults in Turkish and English and offers video consultation.
Accepting international patientsAbout Prof. Hülya Hamzaoğlu, MD
Prof. Hülya Hamzaoğlu, MD is a gastroenterology specialist at Acibadem Fulya Hospital in İstanbul, where she works within the Gastroenterology unit and also treats hemorrhoids and anorectal diseases. Her clinical work covers inflammatory bowel disease, endoscopic evaluation, biliary tract diseases and common digestive complaints such as reflux, gastritis and dyspepsia. She has more than 38 years in medicine.
Dr. Hamzaoğlu graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 1988 and completed internal medicine specialty training at Taksim Training and Research Hospital between 1989 and 1993. She then trained in gastroenterology at Türkiye Yüksek İhtisas Training and Research Hospital, completing this training in 1996. In 1993 she spent time in the Gastroenterology Division of Beth Israel Hospital, Harvard Medical School, in Boston, and in 1997 she worked for one month at Giessen Universitat, Medizische Klinik, in Giessen, Germany. She became Professor at Marmara University Faculty of Medicine, Department of Gastroenterology, in 2004, and in 2004–2005 spent six months at the Inflammatory Bowel Clinic of Beth Israel Deaconess Medical Center, Harvard Medical School. She joined Acıbadem Healthcare Services in 2010. She is a member of the Turkish Gastroenterology Association and the Turkish Liver Research Association, and serves as President of the Inflammatory Bowel Diseases Association. Her published work includes studies on the safety of infliximab in Crohn’s disease, CARD15 variants in Crohn’s disease, thrombophilia in inflammatory bowel disease and the diagnosis of intestinal tuberculosis.
Clinical focus
A central part of Dr. Hamzaoğlu’s practice is inflammatory bowel disease, including the treatment of Crohn’s disease and ulcerative colitis. Management of these chronic conditions usually involves confirming the diagnosis, assessing disease activity and extent, and planning medical therapy and follow-up over time. She also evaluates patients with gastroenteritis, biliary tract diseases, and reflux, gastritis and dyspepsia.
Diagnostic and therapeutic endoscopy is part of her routine work, including gastroscopy, colonoscopy and esophagoscopy, which may be used to investigate symptoms, obtain tissue samples or monitor known disease. In addition, she treats hemorrhoids and other anorectal diseases. Whether a particular procedure is appropriate depends on the individual patient’s symptoms, medical history and previous findings, and is decided after clinical assessment.
How Dr. Hamzaoğlu works with international patients
Dr. Hamzaoğlu consults in Turkish and English, and interpreters can be arranged for other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their situation before traveling or to follow up after treatment.
What Dr. Hamzaoğlu treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceTreatment of hemorrhoids and anorectal diseases
Conditions treated
Education, career and memberships
Education & training
Education
- 2004Marmara University Faculty of Medicine / Professor
- 1996Türkiye Yüksek İhtisas Training and Research Hospital Gastroenterology
- 1993Taksim Training and Research Hospital Internal Medicine
- 1988İstanbul University Cerrahpaşa Faculty of Medicine
Career
Professional Experience
- 2010Acıbadem Healthcare Services
- 2004–2005Beth Israel Deaconess Medical Center, Harvard Medical School, Boston-U.S.A. Inflammatory Bowel Clinic (6 ay)
- 2004Marmara University Faculty of Medicine Department of Gastroenterology, Professor
- 1997Giessen Universitat, Medizische Klinik, Giessen-Germany (1 month)
- 1993–1995Türkiye Yüksek İhtisas Training and Research Hospital, Gastroenterology Clinic
- 1993Beth Israel Hospital, Harvard Medical School Boston-USA, Gastroenterology Division
- 1989–1993Taksim Training and Research Hospital Internal Medicine Specialty Training
Memberships
Professional Memberships
- Turkish Gastroenterology Association
- Inflammatory Bowel Diseases Association (President)
- Turkish Liver Research Association
Selected publications
Selected Publications
- Safety of infliximab in Crohn’s Disease: A large single center experience. Inflam Bowel Dis. 2010 Apr 9. Pub Med PMID: 2088473 Hamzaoglu H, Cooper J, Alsahli M, Falchnuk KR, Peppercorn MA, Farrell RJ.
- What is the most accurate method for the diagnosis of intestinal tuberculosis? Turk J Gastroenterol. 2010 Mar 21(1):91-6 Yonal 0, Hamzaoglu H.
- Dig Dis Sci. 2008 Feb;53(2):481-5. Atug O,Hamzaoglu H, Tahan V, Alican I, Kurtkaya E, Elbuken E, Ozdogan O, Tozun N.
- Distribution of common CARD15 variants in patients with sporadic Crohn’s disease:cases from Turkey. Dig. Dis. Sci. 2006 Apr;51 (4):706 10. Over Hamzaoglu H, Ture F, Gul A, Tozun N, Saruhan-Direskeneli G.
- Prothrombotic gene mutations and Crohn’s disease; is there any association? Hepatogastroenterology. 2005 Sep-Oct;52(65): 1467 -9. Over Hamzaoglu H, Abaci N, Ture F, Alkim C, Tezel N, Avsar E, Tozun N.
- Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension. World J Gastroenterol 2003; 9 :2325-27 Tahan V, Avsar E, Karaca C, Uslu E, Aydm S, Uzun H, Hamzaoglu HO, Besisik F, Kalayci C, Otken A, Tozun N.
- Does Becaplermin (Platelet- Derived Growth Factor-BB) reverse detrimental effects of ischemia on colonic anastomosis. Dis Colon Rectum 2003;46:516-520 Sarıbeyoglu K, Baca B, Hamzaoglu i, Pekmezci S, Karahasanoglu T, Hamzaoglu H.
- Clinical outcome of Crohn’s disease treated with Infliximab. Hepato-Gastroenterology 2003; 50 :952 -56 Arslan S, Kav T, Besisik F, Kaymakoglu S, Pmarbasi B, TOzun N, Over Hamzaoglu H, Duman D, Ulker A, Parlak E, Palabiyikoglu E, Dokmeci A.
- Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease. Endoscopy 1999;31:152-156 Dagli U, Over H, Tezel A, Ulker A, Temucin G.
- Thrombophilia and inflammatory bowel disease; Does FV mutation have a role. Eur J Gastroenterol Hepatol 1998; 10:827 -830 Hamzaoglu HO, Ulgen SK, Tuglular TF, Tezel A, Avsar E.Geyik G, Basgul S, Saydam N, Kalayci C, Ulusoy NB, Tozun N.
- Endoscopic balloon dilation of strictures complicating solitary rectal ulcer syndrome. Endoscopy 1997;29:427 -429 Over H, Ulker A, Baysal C, Dagli U.
- Toothpick impaction; treatment by colonoscopy. Endoscopy 1997; 29:S60-61 Over HH, TOzun N, Avsar E.
- The role of reactive oxygen metabolites in ulcerative colitis. Inflamm bowel dis 1997;3:260-64 Dagli U, Ballk M, Yucel D, Ulker A, Over H, Saydam G, Sahin B.
